NO179249C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 4,6- disubstituerte 2,3-dikarboksylsyreindolderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 4,6- disubstituerte 2,3-dikarboksylsyreindolderivater

Info

Publication number
NO179249C
NO179249C NO930035A NO930035A NO179249C NO 179249 C NO179249 C NO 179249C NO 930035 A NO930035 A NO 930035A NO 930035 A NO930035 A NO 930035A NO 179249 C NO179249 C NO 179249C
Authority
NO
Norway
Prior art keywords
disubstituted
preparation
dicarboxylic acid
indole derivatives
therapeutically active
Prior art date
Application number
NO930035A
Other languages
English (en)
Norwegian (no)
Other versions
NO930035D0 (no
NO930035L (no
NO179249B (no
Inventor
Francesco G Salituro
Bruce M Baron
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO930035D0 publication Critical patent/NO930035D0/no
Publication of NO930035L publication Critical patent/NO930035L/no
Publication of NO179249B publication Critical patent/NO179249B/no
Publication of NO179249C publication Critical patent/NO179249C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO930035A 1990-07-16 1993-01-07 Analogifremgangsmåte for fremstilling av terapeutisk aktive 4,6- disubstituerte 2,3-dikarboksylsyreindolderivater NO179249C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55605790A 1990-07-16 1990-07-16
PCT/US1991/004253 WO1992001670A1 (en) 1990-07-16 1991-06-17 Excitatory amino acid antagonists

Publications (4)

Publication Number Publication Date
NO930035D0 NO930035D0 (no) 1993-01-07
NO930035L NO930035L (no) 1993-01-07
NO179249B NO179249B (no) 1996-05-28
NO179249C true NO179249C (no) 1996-09-04

Family

ID=24219725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930035A NO179249C (no) 1990-07-16 1993-01-07 Analogifremgangsmåte for fremstilling av terapeutisk aktive 4,6- disubstituerte 2,3-dikarboksylsyreindolderivater

Country Status (15)

Country Link
US (1) US5106847A (enExample)
EP (1) EP0539503B1 (enExample)
JP (1) JP3058688B2 (enExample)
KR (1) KR0178469B1 (enExample)
AT (1) ATE136295T1 (enExample)
AU (1) AU646686B2 (enExample)
CA (1) CA2087091C (enExample)
DE (1) DE69118539T2 (enExample)
DK (1) DK0539503T3 (enExample)
ES (1) ES2088011T3 (enExample)
FI (1) FI98455C (enExample)
GR (1) GR3019689T3 (enExample)
HU (1) HU216787B (enExample)
NO (1) NO179249C (enExample)
WO (1) WO1992001670A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
TW280819B (enExample) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5783575A (en) * 1994-03-14 1998-07-21 Novo Nordisk A/S Antagonists, their preparation and use
US5696148A (en) * 1994-03-14 1997-12-09 Novo Nordisk A/S Indole compounds and their use in treating diseases of the central nervous system
US5563157B1 (en) 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
EP0843660A1 (en) * 1995-07-31 1998-05-27 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
IL129187A0 (en) * 1996-09-30 2000-02-17 Hoechst Marion Roussel Inc NMDA (N-methyl-D-aspartate) antagonists
US6214856B1 (en) 1997-03-14 2001-04-10 Smithkline Beecham Corporation Indolecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー　ユニバーシティ ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
CN101815518B (zh) * 2007-06-29 2013-01-09 埃莫里大学 用于神经保护的nmda受体拮抗剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
JP3334087B2 (ja) * 1990-09-10 2002-10-15 アヴェンティス ファーマシューティカルズ インコーポレイテッド 選択的ロイコトリエンｂ▲４▼拮抗剤活性を示す置換された二環式アリール化合物
WO1993005020A1 (en) * 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase

Also Published As

Publication number Publication date
FI930150L (fi) 1993-01-14
FI98455B (fi) 1997-03-14
US5106847A (en) 1992-04-21
FI98455C (fi) 1997-06-25
FI930150A0 (fi) 1993-01-14
KR0178469B1 (ko) 1999-03-20
HU216787B (hu) 1999-08-30
CA2087091A1 (en) 1992-01-17
JPH05508857A (ja) 1993-12-09
JP3058688B2 (ja) 2000-07-04
AU8290891A (en) 1992-02-18
NO930035D0 (no) 1993-01-07
EP0539503A1 (en) 1993-05-05
ES2088011T3 (es) 1996-08-01
CA2087091C (en) 2001-09-11
EP0539503B1 (en) 1996-04-03
ATE136295T1 (de) 1996-04-15
DK0539503T3 (da) 1996-05-13
DE69118539T2 (de) 1996-09-19
WO1992001670A1 (en) 1992-02-06
AU646686B2 (en) 1994-03-03
HU9300100D0 (en) 1993-04-28
HUT67237A (en) 1995-03-28
EP0539503A4 (enExample) 1994-03-23
NO930035L (no) 1993-01-07
NO179249B (no) 1996-05-28
GR3019689T3 (en) 1996-07-31
DE69118539D1 (de) 1996-05-09

Similar Documents

Publication Publication Date Title
NO179249C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4,6- disubstituerte 2,3-dikarboksylsyreindolderivater
AU5378090A (en) Excitatory amino acid antagonists
NO180084C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO178857C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-indolylthioacetatderivater
FI885518A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
FI906084L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 5-(2-metyyli-4,4,4-trifluoributyylikarbamoyyli)indolijohdannaisten valmistamiseksi
FI900145A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI103202B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-sulfonamido-1,4-dihydrokinoliiinijohdannaisten valmistamiseksi
FI922267L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3-isoksatsolyyli-4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
FI893121L (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi
FI905930A7 (fi) Menetelmä uusien, farmakologisesti käyttökelpoisten bispilokarpiinihapon esterijohdannaisten valmistamiseksi
FI910159A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 9a-hydroksi-3-okso- 4,24(25)-stigmastadieeni-26-happojohdannaisten valmistamiseksi
NO880922D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive benzodioksolderivater.
FI910448A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3b/indolijohdannaisten valmistamiseksi
GR1001566B (el) Μέ?οδος παρασκευής νέων παραγώγων βενζοφουρανυλιμιδαζόλης.
NO158254C (no) Analogifremgangsmaate for fremstilling av bicyklo(3,2,1)oktan-karboksylsyrederivater.
NO178375C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive NMDA-antagonister
NO174393C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 eventuelt 21-alkylert
NO884442L (no) Fremgangsmaate for fremstilling av 3,3-disubstituerte indoliner.
NO910564L (no) Fremgangsmaate for fremstilling av azaspiro(4,5)decan-7,9-dionderivater.
FI970396L (fi) Menetelmä terapeuttisesti aktiivisten iminosubstituoitujen syklopent(b)indolijohdannaisten valmistamiseksi
NO883525D0 (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater.
NO883526D0 (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater.